Skip to main content
Signal8
Launch Terminal
Thompson Jaye profile photo

Jaye Thompson

CIK: 0001476971

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Greenwich LifeSciences, Inc. logo
GLSI

Greenwich LifeSciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Greenwich LifeSciences, Inc. logo
    GLSI

    Greenwich LifeSciences, Inc.

    Dec 24, 2024
    Award(A)

    Stock Options

    Direct
    149.8K shares-
  • Greenwich LifeSciences, Inc. logo
    GLSI

    Greenwich LifeSciences, Inc.

    Nov 21, 2024
    Purchase(P)
    Direct
    1K shares at avg. $12.91$13K
  • Greenwich LifeSciences, Inc. logo
    GLSI

    Greenwich LifeSciences, Inc.

    Aug 12, 2024
    Purchase(P)
    Direct
    800 shares at avg. $13.85$11K

1-3 of 3

About Thompson Jaye

Thompson Jaye (SEC CIK 0001476971) files insider reports with the SEC as VP Clinical Reg Affairs of Greenwich LifeSciences, Inc. (GLSI).

Signal8 holds 3 ownership filings by Thompson Jaye, all Form 4s, filed between Sep 16, 2024 and Dec 27, 2024. Those filings report 3 transactions, from Aug 12, 2024 to Dec 24, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Thompson Jaye's filings is in STAFFORD, TX.

Recent filings by Thompson Jaye

  • Dec 24, 2024: Grant or award of GLSI derivative securities (Form 4, code A).
  • Nov 21, 2024: Open-market purchase of GLSI shares (Form 4, code P).
  • Aug 12, 2024: Open-market purchase of GLSI shares (Form 4, code P).

Other insiders filing for Greenwich LifeSciences, Inc. (GLSI)

How to read Form 4 transaction codes